IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
A Novel Validated Gradient Hplc Method For Analysing Axitinib And Their Process Related Impurities By Pda Detection

Author: SHYAMALA, D.ASHOK, P.SHYAM
Abstract: Objectives: The present study mainly intends to develop validated stability indicating method for separation and estimation of axitinib and their process related impurities by Reverse Phase HPLC method. Methods: Axitinib and its three process related impurities (Impurity 1, Impurity 2 and Impurity 3) were efficiently separated on nonpolar standard discovery C8 (250mm x 4.6mmx 5µm) column using mobile phase 0.1% of orthophosphoric(A) acid and methanol(B) on gradient elution. The wavelength for determination of impurities was set at 235nm by PDA detection with flow rate 1ml/min. Results: The resulted chromatograms were examined to be linear and sensitive over the range 0.25-1.5µg/ml for drug and its impurities. Recovery of impurities was found to be in the range of 99-101%. The relative response factors for all three impurities were calculated by slope method. Recovery studies, precision, detection limits and robustness were determined by statistical calculations. No significant degradation was observed during stability studies. Conclusion: The evaluated method was found to be novel and rapid not only applicable for qualitative analysis of axitinib in bulk and drug development process but also for detection of impurities in tablet formulation.
Keyword: Axitinib, process related impurities, HPLC, stability indicating, Relative response factor
DOI: https://doi.org/10.31838/ijpr/2021.13.01.107
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free